New study pits heat, cold, and knife against lung cancer
NCT ID NCT07272356
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares three standard treatments for lung tumors: surgery, targeted radiation (SBRT), and minimally invasive thermal ablation (using heat or cold to destroy tumors). About 68 adults with early-stage lung cancer or limited lung metastases will be followed for two years. Researchers will measure how well each treatment controls cancer, affects breathing, and impacts quality of life, aiming to guide personalized treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Thermal ablation (microwave or cryoablation)
What this could lead to
If successful, this could help doctors choose the best treatment for each patient, balancing cancer control with preserving lung function and quality of life.
What could go wrong
This is a small, non-randomized study with only 68 participants, so results may not apply to everyone. The treatments are already standard, so no major breakthrough is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER, NON-SMALL CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lithuanian University of Health Sciences Kaunas Clinics
Kaunas, 50161, Lithuania